跳转至内容
Merck
CN

Vestibular effects of lidocaine intratympanic injection in rats.

Human & experimental toxicology (2014-02-08)
H H Lee, M J Kim, Y K Jo, J Y Kim, G C Han
摘要

When lidocaine is locally delivered into the inner ear, it rapidly paralyzes the peripheral vestibular afferent neurons and induces unilateral vestibular loss. The goals of this study were to explore the possibility of developing intratympanic injection (IT) of lidocaine as a modality for treating acute vertigo. To evaluate the minimum concentration required, latent time, action duration, and possibility of lidocaine IT readministration to the vestibular system, we compared the development of horizontal nystagmus after IT of 2, 4, 6, 8, and 10% lidocaine solutions in rats. To identify the induction of vestibular compensation, c-Fos-like protein expression was observed in the vestibular nucleus. Results of our investigation showed that lidocaine IT concentrations greater than 4% induced vestibular hyporeflexia in the injected ear. In order to induce hyporeflexia 4 and 6% lidocaine solutions could also be repeatedly injected. Regardless of concentration, effects of the lidocaine IT dissipated gradually over time. Our findings could be used to develop novel methods for symptom control in vestibular disorder patients.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
尿烷, ≥99%
Supelco
利多卡因, Pharmaceutical Secondary Standard; Certified Reference Material
USP
利多卡因, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
尿烷, ≥99.0% (GC)
Supelco
尿烷, analytical standard
利多卡因, European Pharmacopoeia (EP) Reference Standard